Waters Extends the Capability and Power of its High-Resolution Mass Spectrometers
Enhancements for the Waters Xevo G2-XS QTof, SYNAPT XS and SELECT SERIES cyclic IMS instruments accelerate biomedical and pharmaceutical research
biopharmaceuticals
Benchling Raises $50M Series D to Accelerate Biotech Revolution
Life sciences R&D platform to expand product suite and fuel biotech breakthroughs tackling COVID-19 to cancer to climate change
New High-Res Mass Spec Expands Market-Leading Orbitrap Platform
Thermo Scientific Orbitrap Exploris 240 mass spectrometer drives discovery and identification with quantitative precision and accuracy to meet customers’ specific analytical requirements
Wyatt Technology Pioneers Multi-CQA Method for Gene Vectors
AAV analysis allows researchers to determine titer, full:empty capsid ratio, and aggregation in single 30-minute run
Biopharmaceutical Glycan Profiling
Characterizing and profiling glycans is essential for safety and consistency
Sartorius Launches BIOSTAT STR® Generation 3 with BIOBRAIN—Making Biopharmaceutical Development and Production Faster, Simpler, and Safer
Sartorius’ single-use bioreactor and automation platform introduce innovations that will change the field of biopharmaceutical process development and manufacturing
zPREDICTA Enters Strategic Collaboration with LabCorp to Advance the Use of 3D Cell Cultures in Research and Drug Development
The collaboration combines zPREDICTA’s strengths in the development of clinically relevant 3D cell culture models with LabCorp’s strengths in drug development and precision medicine
Sartorius Introduces BioPAT® Spectro to Enable Raman Spectroscopy Capability and QbD with its ambr® and BIOSTAT STR® Platforms
New tool offers access to Raman spectroscopy analysis in high throughput process development
Horizon Discovery Signs Collaboration and License Agreement with Mammoth Biosciences
Company aims to develop the next generation of engineered CHO cell lines to improve production of biotherapeutics
Skills Shortage: Could the Pharmaceutical Industry Be in Trouble?
There is a growing talent gap as the skills of the pharma workforce have not yet aligned with the new world of biopharma manufacturing